Clinical Trial Update: Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for surufatinib in patients with sarcoma including osteosarcoma and soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Surufatinib (Surufatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN